Skip to main content
Clinical Trials/CTRI/2013/02/003432
CTRI/2013/02/003432RecruitingPhase 3

A RANDOMIZED SINGLE BLIND CLINICAL TRIAL TO COMPARE THE ERADICATION RATE, PREVENTION OF ULCER RECURRENCE,SIDE EFFECT, PATIENT COMPLIANCE AND COST EFFECTIVENESS OF SEQUENTIAL VERSUS NON- BISMUTH CONCOMITANT QUADRUPLE THERAPY fOR TREATMENT OF HELICOBACTER PYLORI IN PATIENTS WITH PERFORATED DUODENAL ULCER

JIPMER0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Recruiting
Sponsor
JIPMER
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • ALL CONSECUTIVE PATIENTS AGED MORE THAN 18 YEARS WITH PERFORATED DUODENAL ULCER FOLLOWING SIMPLE CLOSURE WITH H. PYLORI INFECTIO

Exclusion Criteria

  • 1. GASTRIC ULCER PERFORATION
  • 2. PATIENTS UNDERGOING ANY OTHER PROCEDURE APART FROM THE SIMPLE CLOSURE FOR PERFORATED DUODENAL ULCER.
  • 3. PATIENTS WITH ASSOCIATED UPPER GI DISORDERS.
  • 4. PATIENTS PRESENTING WITH REPERFORATION OR OTHER COMPLICATIONS.

Investigators

Sponsor
JIPMER

Similar Trials